Σελίδα 1 από 19 Αποτελέσματα
BACKGROUND OF THE INVENTION
The invention relates generally to bicyclic carbohydrate compounds useful in the treatment of infections caused by Flaviviridae sp. and, more specifically, to such compounds useful in the treatment or amelioration of infections caused by hepatitis C, bovine viral
BACKGROUND OF THE INVENTION
The invention relates generally to the use of sesquiterpene lactones in the treatment of infections caused by Flaviviridae and, more specifically, to the use of sesquiterpene lactone endoperoxides to treat hepatitis C infections, yellow fever, dengue fever, bovine viral
FIELD OF THE INVENTION
This invention relates to the treatment of bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV) infections.
BACKGROUND OF THE INVENTION
Bovine viral diarrhea virus (BVDV) is an enveloped, single-stranded, positive sense RNA virus in the genus Pestivirus and the
FIELD OF THE INVENTION
This invention relates to the treatment of bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV) infections.
BACKGROUND OF THE INVENTION
Bovine viral diarrhea virus (BVDV) is an enveloped, single-stranded, positive sense RNA virus in the genus Pestivirus and the
FIELD OF THE INVENTION
This invention relates to the treatment of bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV) infections.
BACKGROUND OF THE INVENTION
Bovine viral diarrhea virus (BVDV) is an enveloped, single-stranded, positive sense RNA virus in the genus Pestivirus and the
FIELD OF THE INVENTION
This invention relates to the treatment of bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV) infections.
BACKGROUND OF THE INVENTION
Bovine viral diarrhea virus (BVDV) is an enveloped, single-stranded, positive sense RNA virus in the genus Pestivirus and the
FIELD OF THE INVENTION
The present invention relates to a chimeric pestivirus, such as bovine viral diarrhea virus (BVDV), that depends on a hepatitis C virus (HCV) protease function. The invention further relates to using the chimeric, infectious virus to screen for HCV NS3 inhibitor compounds in
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a therapeutic method, more particularly, to a therapeutic method for diseases such as intractable diseases including multiple sclerosis, acute gastroenteritis, viral hepatitis and the like, which are caused by
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to the field of piezoelectric sensors and their use for detecting organic compounds. In particular, the present invention is directed to piezoelectric plate sensors capable of detecting organic compounds in a
BACKGROUND OF THE INVENTION
This invention relates to benzimidazolone derivatives. These compounds have selective cannabinoid(CB)2 receptor binding activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives for the
BACKGROUND OF THE INVENTION
This invention relates to sulfonyl benzimidazole derivatives. These compounds have selective cannabinoid (CB)2 receptor agonistic activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives
BACKGROUND OF THE PRESENT INVENTION
1. Field of Invention
The subject invention relates generally to a series of natural pharmaceutical preparations which can treat hypoproteinemia for increasing albumin. The preparations could be used to treat hypoproteinemia caused by hepatitis virus, human
FIELD OF INVENTION
The present invention relates to molecular approaches to the production of nucleic acid sequences which comprise the genomes of chimeric hepatitis C virus-bovine viral diarrhea viruses (HCV-BVDV). The invention also relates to the use of these chimeric nucleic acid sequences to
FIELD OF THE INVENTION
The present invention relates to benzimidazole compounds and their use in inhibiting picornaviruses and flaviviruses.
BACKGROUND
The incidence of viral upper respiratory disease, the common cold, is immense. It has been estimated that nearly a billion cases annually appear in
FIELD OF INVENTION
This invention is a woodchuck or woodchuck cell infected with a bovine viral diarrhea virus and their use as models of Flaviviridae infection.
BACKGROUND OF THE INVENTION
Infection with hepatitis C virus (HCV) has a major medical impact worldwide leading to chronic infections,